Recent HbA1c values and mortality risk in type 2 diabetes. population-based case-control study.
This study aimed to evaluate mortality within 365 days of HbA1c values of <6.5% or >9.0% in participants with clinical type 2 diabetes mellitus. A matched nested case-control study was implemented, within a cohort of participants with type 2 diabetes from 2000 to 2008. Conditional logistic reg...
Guardado en:
Autores principales: | Jennifer Nicholas, Judith Charlton, Alex Dregan, Martin C Gulliford |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f825f59b1be345d6b9301bfd95568df1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Diagnostic and Prognostic Value of Glycated Hemoglobin (HbA1c) in Patients with Diabetes Mellitus and Thalassemia
por: Yordanov E., et al.
Publicado: (2020) -
Prognostic value of HbA1C in predicting the short term outcome in diabetic patients with ACS
por: Anil Kumar, et al.
Publicado: (2021) -
HbA1c measured in stored erythrocytes is positively linearly associated with mortality in individuals with diabetes mellitus.
por: Diewertje Sluik, et al.
Publicado: (2012) -
A study assessing the association of glycated hemoglobin A1C (HbA1C) associated variants with HbA1C, chronic kidney disease and diabetic retinopathy in populations of Asian ancestry.
por: Peng Chen, et al.
Publicado: (2013) -
Features of glycemic variations in drug naïve type 2 diabetic patients with different HbA1c values
por: Feng-fei Li, et al.
Publicado: (2017)